MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-025-86314-2

Медицинская библиотека · Scientific reports · 2025

Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids.

Sridhar Arun, Bakke Ingunn, Gopalakrishnan Shreya, Osoble Nimo Mukhtar Mohamud, Hammarqvist Emilie Prytz, Pettersen Henrik P Sahlin, Sandvik Arne Kristian, Østvik Ann Elisabet, Hansen Marianne Doré, Bruland Torunn

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Restoration of the intestinal epithelial barrier is crucial for achieving mucosal healing, the therapeutic goal for inflammatory bowel disease (IBD). During homeostasis, epithelial renewal is maintained by crypt stem cells and progenitors that cease to divide as they differentiate into mature colonocytes. Inflammation is a major effector of mucosal damage in IBD and has been found to affect epithelial stemness, regeneration and cellular functions. However, the impact of immune cell-modulating IBD drugs on epithelial homeostasis and repair is poorly understood. It is likely that these drugs will have distinct mechanisms of action (MOA) in intestinal epithelium relevant for homeostasis that will vary among patients. We investigated cellular effects of pan-Janus Kinase (JAK) inhibitor tofacitinib and the corticosteroid budesonide on uninflamed and TNF + Poly(I:C) stimulated human colon organoids (colonoids) from healthy donors and IBD-patients. Our findings reveal that although both tofacitinib and budesonide exhibit anti-inflammatory effects, tofacitinib increased colonoid size and proliferation during differentiation, and promoted epithelial stemness. In contrast, budesonide decreased colonoid size and showed no consistent effect on proliferation or stemness. Our study demonstrates the value of employing human colonoids to investigate how IBD drugs affect intestinal epithelial cells and inter-individual variations relevant to mucosal healing and personalized IBD treatment.

Для цитирования: Sridhar Arun, Bakke Ingunn, Gopalakrishnan Shreya, Osoble Nimo Mukhtar Mohamud, Hammarqvist Emilie Prytz, Pettersen Henrik P Sahlin, Sandvik Arne Kristian, Østvik Ann Elisabet, Hansen Marianne Doré, Bruland Torunn. Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids.. Scientific reports. 2025. DOI: 10.1038/s41598-025-86314-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.